Masso Torrence Wealth Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Masso Torrence Wealth Management's EXAS Position: Q1 2022 in Review
Masso Torrence Wealth Management sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 475 shares — an estimated $37K sold.
Masso Torrence Wealth Management first reported a position in EXAS in Q4 2021 and held it in 1 quarter. The position peaked at $37K in Q4 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.
- Masso Torrence Wealth Management reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
- Masso Torrence Wealth Management sold 475 Exact Sciences shares in Q1 2022, an estimated $37K.
- Masso Torrence Wealth Management first reported a position in Exact Sciences in Q4 2021 and held it in 1 quarter.
- Masso Torrence Wealth Management's Exact Sciences position peaked at $37K in Q4 2021.
- 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.
Based on Masso Torrence Wealth Management's 13F filing for Q1 2022, filed 26 Apr 2022.